NCT05438095

Medication Adherence in Patients With Sarcoidosis

Medication Adherence and Clinical Outcomes in Sarcoidosis

• Status: Active Not Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 150 (estimated)
• Sponsor: Johns Hopkins University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The goal of the study is to look at the relationship between how individuals with Sarcoidosis take the sarcoidosis medicines and how it affects the disease, to evaluate any factors that may make individuals not want to take the medicines, and to develop and refine ways to help support individuals with Sarcoidosis especially when it comes to the medicines. The overall hypothesis is higher medication adherence will be associated with better clinical outcomes in sarcoidosis. The investigators will enroll 150 patients with biopsy proven pulmonary sarcoidosis for at least one year who are on any oral treatment regimen for at least six months into a 12-month longitudinal study.

Conditions

• Medication Adherence
• Sarcoidosis

Timeline

• Start date: 2022-05-11
• Primary completion: 2026-08-31
• Completion: 2026-08-31
• First posted: 2022-06-29
• Last updated: 2025-12-11

Locations

2 sites across 1 country: United States